- Home
- CNVS vs ALGS Comparison
CNVS vs ALGS Comparison
Compare CNVS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNVS
- ALGS
- Stock Information
- Founded
- CNVS 2000
- ALGS 2018
- Country
- CNVS United States
- ALGS United States
- Employees
- CNVS N/A
- ALGS N/A
- Industry
- CNVS Consumer Electronics/Video Chains
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- CNVS Consumer Discretionary
- ALGS Health Care
- Exchange
- CNVS Nasdaq
- ALGS Nasdaq
- Market Cap
- CNVS 22.8M
- ALGS 23.5M
- IPO Year
- CNVS 2003
- ALGS 2020
- Fundamental
- Price
- CNVS $3.20
- ALGS $19.17
- Analyst Decision
- CNVS Buy
- ALGS Strong Buy
- Analyst Count
- CNVS 1
- ALGS 1
- Target Price
- CNVS $10.00
- ALGS $75.00
- AVG Volume (30 Days)
- CNVS 490.5K
- ALGS 476.7K
- Earning Date
- CNVS 11-14-2024
- ALGS 11-06-2024
- Dividend Yield
- CNVS N/A
- ALGS N/A
- EPS Growth
- CNVS N/A
- ALGS N/A
- EPS
- CNVS N/A
- ALGS N/A
- Revenue
- CNVS $45,005,000.00
- ALGS $5,997,000.00
- Revenue This Year
- CNVS $31.52
- ALGS N/A
- Revenue Next Year
- CNVS N/A
- ALGS N/A
- P/E Ratio
- CNVS N/A
- ALGS N/A
- Revenue Growth
- CNVS N/A
- ALGS N/A
- 52 Week Low
- CNVS $0.72
- ALGS $6.76
- 52 Week High
- CNVS $3.93
- ALGS $30.00
- Technical
- Relative Strength Index (RSI)
- CNVS 68.21
- ALGS 82.79
- Support Level
- CNVS $2.48
- ALGS $15.66
- Resistance Level
- CNVS $3.30
- ALGS $21.89
- Average True Range (ATR)
- CNVS 0.33
- ALGS 2.25
- MACD
- CNVS -0.01
- ALGS 1.24
- Stochastic Oscillator
- CNVS 69.23
- ALGS 79.79
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.